Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-03-28 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased shares under a stock buyback program, referencing a previous company announcement. This action directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document is very short and announces the activity, which fits the nature of a POS filing.
2014-03-28 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly details the purchase of shares by Novozymes under a previously announced stock buyback program. It mentions specific transaction values and dates related to share repurchases. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back its own shares. The document length is very short (607 chars) and ends with 'Read the full announcement in PDF format', which might suggest RPA/RNS, but the core content is a specific transaction report, making POS the most accurate classification for the *subject matter* being reported, rather than just the announcement of the report itself.
2014-03-21 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text, written in Danish, explicitly discusses the purchase of Novozymes' own B-shares as part of a share buyback program ('aktietilbagekøbsprogram'). It details the number of shares bought and the total value, referencing a previous announcement (nr. 17, 2014) and regulatory compliance (Safe Harbour Regulation). This activity directly corresponds to the definition of 'Transaction in Own Shares'. The document length is very short (582 chars) and ends with a prompt to read the full announcement in PDF format, which might suggest RPA/RNS, but the core content is definitively about share repurchase, making 'POS' the most specific classification.
2014-03-21 Danish
Director's Dealing 2014
Director's Dealing
2014-03-14 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions where Novozymes has bought back its own shares ('aktietilbagekøbsprogram') as part of a defined program. It lists the number of shares bought, the average price, and the total transaction value for specific dates (March 7th to March 13th, 2014). This activity directly corresponds to the definition of a company repurchasing its own stock. The filing type code 'POS' (Transaction in Own Shares) is the most accurate classification for this content, as it is a report of share repurchase activity.
2014-03-14 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly corresponds to the company transacting in its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit. The document is very short and mentions reading the full announcement in PDF format, which might suggest RPA, but the core content is a specific transaction report, making POS the primary classification.
2014-03-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.